These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 12656423)

  • 1. Cross-sectional analysis of hearing threshold in relation to age in a large family with cochleovestibular impairment thoroughly genotyped for DFNA9/COCH.
    Bom SJ; Kemperman MH; Huygen PL; Luijendijk MW; Cremers CW
    Ann Otol Rhinol Laryngol; 2003 Mar; 112(3):280-6. PubMed ID: 12656423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Audiometric, vestibular, and genetic aspects of a DFNA9 family with a G88E COCH mutation.
    Kemperman MH; De Leenheer EM; Huygen PL; van Duijnhoven G; Morton CC; Robertson NG; Cremers FP; Kremer H; Cremers CW
    Otol Neurotol; 2005 Sep; 26(5):926-33. PubMed ID: 16151339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vestibular deterioration precedes hearing deterioration in the P51S COCH mutation (DFNA9): an analysis in 74 mutation carriers.
    Bischoff AM; Huygen PL; Kemperman MH; Pennings RJ; Bom SJ; Verhagen WI; Admiraal RJ; Kremer H; Cremers CW
    Otol Neurotol; 2005 Sep; 26(5):918-25. PubMed ID: 16151338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive cochleovestibular impairment caused by a point mutation in the COCH gene at DFNA9.
    Bom SJ; Kemperman MH; De Kok YJ; Huygen PL; Verhagen WI; Cremers FP; Cremers CW
    Laryngoscope; 1999 Sep; 109(9):1525-30. PubMed ID: 10499067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hereditary cochleovestibular dysfunction due to a COCH gene mutation (DFNA9): a follow-up study of a family.
    Verhagen WI; Bom SJ; Fransen E; Van Camp G; Huygen PL; Theunissen EJ; Cremers CW
    Clin Otolaryngol Allied Sci; 2001 Dec; 26(6):477-83. PubMed ID: 11843927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotype description of a novel DFNA9/COCH mutation, I109T.
    Pauw RJ; Huygen PL; Collin RW; Cruysberg JR; Hoefsloot LH; Kremer H; Cremers CW
    Ann Otol Rhinol Laryngol; 2007 May; 116(5):349-57. PubMed ID: 17561763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vertical corneal striae in families with autosomal dominant hearing loss: DFNA9/COCH.
    Bischoff AM; Pauw RJ; Huygen PL; Aandekerk AL; Kremer H; Cremers CW; Cruysberg JR
    Am J Ophthalmol; 2007 May; 143(5):847-852. PubMed ID: 17368553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotype analysis of an Australian DFNA9 family with the 1109N COCH mutation.
    Pauw RJ; Huygen PL; Colditz GM; Cremers CW
    Ann Otol Rhinol Laryngol; 2011 Jun; 120(6):414-21. PubMed ID: 21774451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics of a Dutch DFNA9 family with a novel COCH mutation, G87W.
    Pauw RJ; Collin RW; Huygen PL; Hoefsloot LH; Kremer H; Cremers CW
    Audiol Neurootol; 2007; 12(2):77-84. PubMed ID: 17264471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive late-onset sensorineural hearing loss and vestibular impairment with vertigo (DFNA9/COCH): longitudinal analyses in a belgian family.
    Lemaire FX; Feenstra L; Huygen PL; Fransen E; Devriendt K; Van Camp G; Vantrappen G; Cremers CW; Wackym PA; Koss JC
    Otol Neurotol; 2003 Sep; 24(5):743-8. PubMed ID: 14501450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A common ancestor for COCH related cochleovestibular (DFNA9) patients in Belgium and The Netherlands bearing the P51S mutation.
    Fransen E; Verstreken M; Bom SJ; Lemaire F; Kemperman MH; De Kok YJ; Wuyts FL; Verhagen WI; Huygen PL; McGuirt WT; Smith RJ; Van Maldergem LV; Declau F; Cremers CW; Van De Heyning PH; Cremers FP; Van Camp G
    J Med Genet; 2001 Jan; 38(1):61-5. PubMed ID: 11332404
    [No Abstract]   [Full Text] [Related]  

  • 12. A Pro51Ser mutation in the COCH gene is associated with late onset autosomal dominant progressive sensorineural hearing loss with vestibular defects.
    de Kok YJ; Bom SJ; Brunt TM; Kemperman MH; van Beusekom E; van der Velde-Visser SD; Robertson NG; Morton CC; Huygen PL; Verhagen WI; Brunner HG; Cremers CW; Cremers FP
    Hum Mol Genet; 1999 Feb; 8(2):361-6. PubMed ID: 9931344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cochlin immunostaining of inner ear pathologic deposits and proteomic analysis in DFNA9 deafness and vestibular dysfunction.
    Robertson NG; Cremers CW; Huygen PL; Ikezono T; Krastins B; Kremer H; Kuo SF; Liberman MC; Merchant SN; Miller CE; Nadol JB; Sarracino DA; Verhagen WI; Morton CC
    Hum Mol Genet; 2006 Apr; 15(7):1071-85. PubMed ID: 16481359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic review of hearing and vestibular function in carriers of the Pro51Ser mutation in the COCH gene.
    JanssensdeVarebeke S; Topsakal V; Van Camp G; Van Rompaey V
    Eur Arch Otorhinolaryngol; 2019 May; 276(5):1251-1262. PubMed ID: 30806805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotype-phenotype Correlation Study in a Large Series of Patients Carrying the p.Pro51Ser (p.P51S) Variant in COCH (DFNA9): Part I-A Cross-sectional Study of Hearing Function in 111 Carriers.
    JanssensdeVarebeke SPF; Moyaert J; Fransen E; Bulen B; Neesen C; Devroye K; van de Berg R; Pennings RJE; Topsakal V; Vanderveken O; Van Camp G; Van Rompaey V
    Ear Hear; 2021 Nov-Dec 01; 42(6):1508-1524. PubMed ID: 34369416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Dutch family with hearing loss linked to the DFNA20/26 locus: longitudinal analysis of hearing impairment.
    Kemperman MH; De Leenheer EM; Huygen PL; van Wijk E; van Duijnhoven G; Cremers FP; Kremer H; Cremers CW
    Arch Otolaryngol Head Neck Surg; 2004 Mar; 130(3):281-8. PubMed ID: 15023833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The DFNA10 phenotype.
    De Leenheer EM; Huygen PL; Wayne S; Smith RJ; Cremers CW
    Ann Otol Rhinol Laryngol; 2001 Sep; 110(9):861-6. PubMed ID: 11558763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel DFNA9 mutation in the vWFA2 domain of COCH alters a conserved cysteine residue and intrachain disulfide bond formation resulting in progressive hearing loss and site-specific vestibular and central oculomotor dysfunction.
    Street VA; Kallman JC; Robertson NG; Kuo SF; Morton CC; Phillips JO
    Am J Med Genet A; 2005 Dec; 139A(2):86-95. PubMed ID: 16261627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DFNA9/COCH and its phenotype.
    Kemperman MH; Bom SJ; Lemaire FX; Verhagen WI; Huygen PL; Cremers CW
    Adv Otorhinolaryngol; 2002; 61():66-72. PubMed ID: 12408065
    [No Abstract]   [Full Text] [Related]  

  • 20. The phenotype of DFNA13/COL11A2: nonsyndromic autosomal dominant mid-frequency and high-frequency sensorineural hearing impairment.
    Kunst H; Huybrechts C; Marres H; Huygen P; Van Camp G; Cremers C
    Am J Otol; 2000 Mar; 21(2):181-7. PubMed ID: 10733181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.